All tenders
75F40125C00098
DO LABORATORY PRESCRIBED AND AD LIBITUM USE SESSIONS REPRESENT REAL-WORLD ENDS USE
Food and Drug Administration · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedOtherFederal
Basic information
- Reference number
- 75F40125C00098
- Issuing organization
- Food and Drug Administration · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- DO LABORATORY PRESCRIBED AND AD LIBITUM USE SESSIONS REPRESENT REAL-WORLD ENDS USE
- Source
- USASpending (Federal)
- Source ID
- usa-75F40125C00098
Details
- Location
- United States
Description
DO LABORATORY PRESCRIBED AND AD LIBITUM USE SESSIONS REPRESENT REAL-WORLD ENDS USE Awarded to: ROCHESTER INSTITUTE OF TECHNOLOGY Agency: Department of Health and Human Services Sub-agency: Food and Drug Administration Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2025/09/30 12:00:00 AM UTC
- Closing date
- 2029/09/24 12:00:00 AM UTC
Estimated value
$4.5M USD
Classification
Normalized category
Other